BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31577961)

  • 21. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.
    Guilmette JM; Nosé V
    Adv Anat Pathol; 2019 Jan; 26(1):13-30. PubMed ID: 29912000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.
    Haugvik SP; Kaemmerer D; Gaujoux S; Labori KJ; Verbeke CS; Gladhaug IP
    Curr Oncol Rep; 2016 May; 18(5):28. PubMed ID: 26984415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Tract Large Cell Neuroendocrine Carcinoma: Diagnostic, Prognostic and Therapeutic Issues.
    Sanguedolce F; Calò B; Chirico M; Tortorella S; Carrieri G; Cormio L
    Anticancer Res; 2020 May; 40(5):2439-2447. PubMed ID: 32366387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role of radiotherapy in the management of pancreatic neuroendocrine tumors (PNET)?
    Saif MW; Ng J; Chang B; Russo S
    JOP; 2012 Mar; 13(2):174-6. PubMed ID: 22406594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.
    Jamali M; Chetty R
    Endocr Pathol; 2008; 19(4):282-8. PubMed ID: 18931958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational research in neuroendocrine tumors: pitfalls and opportunities.
    Capdevila J; Casanovas O; Salazar R; Castellano D; Segura A; Fuster P; Aller J; García-Carbonero R; Jimenez-Fonseca P; Grande E; Castaño JP
    Oncogene; 2017 Apr; 36(14):1899-1907. PubMed ID: 27641330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics.
    Otto R; Detjen KM; Riemer P; Fattohi M; Grötzinger C; Rindi G; Wiedenmann B; Sers C; Leser U
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.
    Kidd M; Modlin I; Öberg K
    Nat Rev Clin Oncol; 2016 Nov; 13(11):691-705. PubMed ID: 27273044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K
    Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poorly Differentiated and Undifferentiated Pancreatic Neuroendocrine Carcinoma Management and Outcomes: A Surveillance, Epidemiology, and End Results Assessment.
    Gan Y; Su S; Fang C; Li C; Wen TF
    Pancreas; 2022 Apr; 51(4):e64-e65. PubMed ID: 35687071
    [No Abstract]   [Full Text] [Related]  

  • 32. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.
    Bevere M; Gkountakos A; Martelli FM; Scarpa A; Luchini C; Simbolo M
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast Carcinoma With Unrecognized Neuroendocrine Differentiation Metastasizing to the Pancreas: A Potential Diagnostic Pitfall.
    Christensen L; Mortensen MB; Detlefsen S
    Int J Surg Pathol; 2016 Aug; 24(5):463-7. PubMed ID: 26912472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological and molecular evaluation of pancreatic neoplasms.
    Rishi A; Goggins M; Wood LD; Hruban RH
    Semin Oncol; 2015 Feb; 42(1):28-39. PubMed ID: 25726050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
    Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
    J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Raj N; Fazio N; Strosberg J
    Am Soc Clin Oncol Educ Book; 2018 May; 38():292-299. PubMed ID: 30231344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic neuroendocrine tumors: a review.
    Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
    Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Rosiek V; Borowska M; Bałdys-Waligórska A; Bednarczuk T; Blicharz-Dorniak J; Bolanowski M; Boratyn-Nowicka A; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak F; Hubalewska-Dydejczyk A; Jarząb B; Jarząb M; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nowakowska-Duława E; Pilch-Kowalczyk J; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Strzelczyk J; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W
    Endokrynol Pol; 2017; 68(2):169-197. PubMed ID: 28540973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased autophagy/mitophagy levels in primary tumours of patients with pancreatic neuroendocrine neoplasms.
    Daskalakis K; Alexandraki KI; Kloukina I; Kassi E; Felekouras E; Xingi E; Pagakis SN; Tsolakis AV; Andreakos E; Kaltsas G; Kambas K
    Endocrine; 2020 May; 68(2):438-447. PubMed ID: 32114655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.